CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $863,000 | -57.2% | 12,685 | -48.2% | 0.00% | -66.7% |
| Q3 2017 | $2,018,000 | -49.7% | 24,485 | -42.9% | 0.00% | -50.0% |
| Q2 2017 | $4,012,000 | +561.0% | 42,852 | +349.8% | 0.01% | +500.0% |
| Q1 2017 | $607,000 | -20.7% | 9,526 | -44.7% | 0.00% | 0.0% |
| Q4 2016 | $765,000 | -30.9% | 17,226 | -43.9% | 0.00% | -50.0% |
| Q3 2016 | $1,107,000 | +123.6% | 30,700 | -15.0% | 0.00% | +100.0% |
| Q2 2016 | $495,000 | -29.6% | 36,100 | -1.4% | 0.00% | 0.0% |
| Q1 2016 | $703,000 | -46.9% | 36,600 | -3.2% | 0.00% | -66.7% |
| Q4 2015 | $1,323,000 | -69.3% | 37,800 | -19.2% | 0.00% | -62.5% |
| Q3 2015 | $4,304,000 | +2.5% | 46,800 | -2.1% | 0.01% | 0.0% |
| Q2 2015 | $4,201,000 | +4.8% | 47,800 | -11.5% | 0.01% | +14.3% |
| Q1 2015 | $4,008,000 | +43.7% | 54,000 | +8.4% | 0.01% | +40.0% |
| Q4 2014 | $2,789,000 | +149.0% | 49,800 | +101.6% | 0.01% | +150.0% |
| Q3 2014 | $1,120,000 | +5.3% | 24,700 | -3.9% | 0.00% | 0.0% |
| Q2 2014 | $1,064,000 | -12.7% | 25,700 | +46.0% | 0.00% | 0.0% |
| Q1 2014 | $1,219,000 | +21.1% | 17,600 | +5.4% | 0.00% | 0.0% |
| Q4 2013 | $1,007,000 | +62.4% | 16,700 | +63.7% | 0.00% | +100.0% |
| Q3 2013 | $620,000 | -9.2% | 10,200 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $683,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |